[HTML][HTML] Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway
S Wang, Y Chen, S Han, Y Liu, J Gao, Y Huang… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Acute kidney injury (AKI) is a common critical illness in the clinic and currently
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway
S Wang, Y Chen, S Han, Y Liu, J Gao… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Rationale: Acute kidney injury (AKI) is a common critical illness in the clinic and currently
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway.
S Wang, Y Chen, S Han, Y Liu, J Gao, Y Huang… - Theranostics, 2022 - europepmc.org
Rationale: Acute kidney injury (AKI) is a common critical illness in the clinic and currently
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway
S Wang, Y Chen, S Han, Y Liu, J Gao, Y Huang… - …, 2022 - search.proquest.com
Rationale: Acute kidney injury (AKI) is a common critical illness in the clinic and currently
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway.
S Wang, Y Chen, S Han, Y Liu, J Gao, Y Huang… - Theranostics, 2022 - europepmc.org
Rationale: Acute kidney injury (AKI) is a common critical illness in the clinic and currently
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …
lacks effective treatment options. Ischemia reperfusion injury (IRI) is a major pathogenic …